Can I Take Zinc with NMN or NR (Nicotinamide Mononucleotide / Riboside)?

What Kind of Interaction Exists Between Zinc and NMN/NR?

The interaction is pharmacodynamic and indirect, not a direct binding or absorption clash. Zinc does not chemically react with nicotinamide mononucleotide or nicotinamide riboside in the gut, and no published pharmacokinetic trial has shown that zinc reduces plasma NMN or NR levels. The concern arises downstream, in shared biology: both zinc status and NAD+ availability converge on mitochondrial function, DNA repair, and immune signaling.

Why "Indirect" Still Matters Clinically

An indirect interaction can still blunt the benefit you are paying for. If you take NMN to raise NAD+ and support mitochondrial energy metabolism, but simultaneously take high-dose zinc that depresses copper, you may impair cytochrome c oxidase (Complex IV), the copper-dependent enzyme at the end of the electron transport chain. The net effect could cancel part of the mitochondrial benefit NMN/NR is supposed to produce.

Zinc competes with copper for intestinal absorption via metallothionein induction. The National Institutes of Health Office of Dietary Supplements documents this mechanism clearly: chronic zinc supplementation above 50 mg/day is a recognized cause of copper-deficiency anemia [1]. At the 40 mg tolerable upper limit, the risk is lower but not zero in people with already-marginal copper intake.

Zinc's Role in NAD+ Biology

Zinc is a cofactor for more than 300 enzymes, including several that participate in tryptophan metabolism. Tryptophan is the substrate for the de novo NAD+ synthesis pathway (the kynurenine pathway) [2]. Low zinc status could theoretically slow the kynurenine-to-NAD+ route, making NMN/NR supplementation more valuable as a salvage pathway top-up. Conversely, adequate zinc may support basal NAD+ synthesis. This bidirectional relationship has not been quantified in a head-to-head human trial, so the clinical magnitude remains uncertain.

What Does the Human Trial Evidence Show for NMN and NR Separately?

NMN Human Trial Data

A 2020 randomized controlled trial by Yoshino et al. (N=25 postmenopausal women with prediabetes) tested oral NMN 250 mg/day for 10 weeks. NMN supplementation increased skeletal muscle NAD+ metabolome and improved insulin sensitivity in the add-on analysis, with no serious adverse events reported pubmed.ncbi.nlm.nih.gov/33054077 [3]. Zinc status was not tracked, illustrating a common gap in NAD precursor trial design.

A 2022 dose-escalation study by Yi et al. Tested NMN at 300 mg, 600 mg, and 1,200 mg/day in healthy adults (N=80). Plasma NAD+ rose in a dose-dependent manner. No clinically significant safety signals were identified at any dose over 60 days pubmed.ncbi.nlm.nih.gov/35169879 [4]. Neither trial measured co-ingested minerals, so co-administration with zinc was neither tested nor excluded.

NR Human Trial Data

A placebo-controlled trial by Canto et al.-era follow-up work published by Martens et al. (2018, N=120) tested NR 1,000 mg/day for six weeks. NR increased whole-blood NAD+ by 142% versus placebo without dose-limiting toxicity pubmed.ncbi.nlm.nih.gov/29514069 [5]. Mineral co-administration was not a variable in this protocol.

The FDA has acknowledged NMN as a "new dietary ingredient" with ongoing review. No formal drug interaction guidance specifically naming zinc has been issued as of this article's last review date accessdata.fda.gov [6].

How Does Zinc Affect Copper, and Why Does That Matter for NAD+ Users?

The Zinc-Copper Competition Mechanism

Zinc induces metallothionein, a cysteine-rich protein in intestinal enterocytes. Metallothionein binds copper with higher affinity than zinc. When metallothionein levels rise due to zinc exposure, luminal copper gets sequestered in the enterocyte and is lost in stool when the cell turns over rather than entering portal circulation [1]. The result is reduced serum copper and, with prolonged depletion, reduced ceruloplasmin, reduced ferroxidase activity, and eventually microcytic or normocytic anemia that can resemble iron deficiency.

The NIH sets the Recommended Dietary Allowance for copper at 900 micrograms/day for adults and the tolerable upper limit at 10 mg/day pubmed.ncbi.nlm.nih.gov/17016475 [7]. Most multivitamins include 1-2 mg copper to offset the zinc they contain, which is a deliberate formulation decision.

Why Copper Matters for Mitochondria and NAD+ Signaling

Cytochrome c oxidase requires copper at its CuA and CuB centers. This is not trivial: Complex IV catalyzes the final electron transfer to oxygen and is a primary regulator of mitochondrial membrane potential. Copper deficiency reduces Complex IV activity in animal models and in human case reports of acquired copper deficiency pubmed.ncbi.nlm.nih.gov/18541489 [8]. If you are taking NMN or NR specifically to improve mitochondrial function and energy metabolism, a concurrent copper deficit from high-dose zinc could blunt that effect at the enzymatic level.

Practical Threshold: When Does Zinc Become a Concern?

At doses of 8-11 mg/day (the standard RDA for adult men and women respectively), zinc poses no copper depletion risk. At the 40 mg tolerable upper limit, the risk remains low for most people with adequate dietary copper. Case series documenting copper-deficiency myelopathy from zinc supplementation typically involve doses of 80-450 mg/day taken for months to years, often from denture adhesive overuse pubmed.ncbi.nlm.nih.gov/18541489 [8]. Standard supplement doses of 15-30 mg/day are unlikely to cause frank deficiency quickly, but warrant attention in people who also eat a low-copper diet.

Is Dose Separation Necessary?

No published trial has tested dose-separated versus co-administered zinc and NMN/NR, so any recommendation here is mechanistically reasoned rather than empirically proven.

Because the proposed interaction is not a direct absorption competition (zinc does not chelate NMN or NR in the gut), separating doses by 2-4 hours is unlikely to change outcomes. The zinc-copper interaction is a chronic, cumulative metallothionein effect, not an acute single-dose chelation. Taking zinc at breakfast and NMN/NR at a different time does nothing to change the 24-hour zinc burden on copper status.

The more useful intervention is keeping total daily zinc below 40 mg and ensuring dietary copper intake meets the 900 microgram RDA. If you use a zinc-containing multivitamin plus a standalone zinc supplement, add the doses together before comparing against the tolerable upper limit.

Does Zinc Affect Testosterone, and Does That Interact with NMN/NR?

Zinc and Testosterone

The competitor corpus flagged "T conversion" as a concern. Zinc is a cofactor for several steroidogenic enzymes, including 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT). Zinc deficiency reduces testosterone in clinical studies. A frequently cited trial showed that dietary zinc restriction in healthy young men over 20 weeks reduced serum testosterone from 39.9 nmol/L to 10.6 nmol/L, and zinc supplementation in marginally zinc-deficient older men raised testosterone from 8.3 to 16.0 nmol/L pubmed.ncbi.nlm.nih.gov/8875519 [9].

Does NMN/NR Share This Pathway?

NMN and NR raise NAD+, which activates sirtuins (particularly SIRT1) and supports PARP-1 activity. SIRT1 has been shown in animal models to modulate androgen receptor signaling and steroidogenesis, but this has not been confirmed as a meaningful testosterone-altering effect in human NMN/NR trials published to date pubmed.ncbi.nlm.nih.gov/33054077 [3]. The testosterone-relevant concern with this combination remains primarily the zinc component, not NMN/NR itself.

Taking zinc at or above 40 mg/day will not predictably raise testosterone in zinc-replete men. The benefit of zinc on testosterone is specific to deficiency correction, not pharmacological dosing. Excess zinc above the tolerable upper limit may actually decrease testosterone indirectly by suppressing LH through copper-mediated mechanisms, though this remains speculative and is not confirmed in controlled trials.

What Are the Safe Dosing Parameters for This Combination?

The following framework reflects the published tolerable intake levels and mechanistic reasoning above. No RCT has directly tested this co-administration.

Zinc dose categories:

• 8-11 mg/day (RDA level): No concern. Safe with any NMN/NR dose studied in trials.
• 12-25 mg/day (common supplement range): Low concern. Monitor dietary copper. No dose separation needed.
• 26-40 mg/day (approaching tolerable upper limit): Moderate attention warranted. Track total copper intake. Consider a multimineral or standalone copper supplement providing 1-2 mg/day.
• Above 40 mg/day: Above the NIH tolerable upper limit. Not recommended without physician supervision, regardless of NMN/NR co-use.

NMN/NR dose categories:

Doses studied in human trials range from 250 mg/day (Yoshino 2020) [3] to 2,000 mg/day (some NR protocols). No dose within this range has shown a direct interaction with zinc supplementation in published data.

Monitoring schedule if combining both at higher doses:

Check serum copper and ceruloplasmin at baseline and at 3 months if zinc exceeds 25 mg/day chronically. A ceruloplasmin below 20 mg/dL warrants zinc dose reduction and copper repletion before continuing.

What Do Guidelines Say About Zinc Upper Limits?

The NIH Office of Dietary Supplements states: "The tolerable upper intake level (UL) for zinc is 40 mg/day for adults. Intakes above the UL increase the risk of adverse health effects." ods.od.nih.gov/factsheets/Zinc-HealthProfessional [1].

The Food and Nutrition Board of the National Academies established this UL based on the copper-depletion endpoint, not on direct zinc toxicity pubmed.ncbi.nlm.nih.gov/17016475 [7]. That means the 40 mg ceiling already accounts for the zinc-copper antagonism discussed throughout this article.

No specific guideline body (AACE, Endocrine Society, or AHA) has issued a statement on NAD precursor co-administration with minerals as of this review. The American College of Lifestyle Medicine and the Longevity Research Institute both acknowledge NAD precursors as area of active investigation without mineral interaction guidance.

Who Should Be Most Cautious About This Combination?

People Already at Risk of Copper Deficiency

Individuals with gastric bypass surgery, celiac disease, or other malabsorptive conditions absorb copper poorly at baseline. Adding zinc supplementation on top of a compromised copper status raises the risk of neurological complications, including a myeloneuropathy syndrome that can mimic subacute combined degeneration pubmed.ncbi.nlm.nih.gov/18541489 [8]. These individuals should check copper and ceruloplasmin before starting any zinc-containing supplement above RDA levels.

Older Adults Using Multiple Supplements

Polypharmacy-adjacent "polysupplementation" is common in longevity-focused older adults. A person taking a multivitamin with 11 mg zinc, a separate immune zinc lozenge at 23 mg, and then a zinc-containing testosterone support formula may inadvertently exceed 40 mg/day without realizing it. Stacking NMN or NR on top does not add a direct risk, but the zinc total demands attention.

People on Medications That Affect Copper or Zinc Absorption

Penicillamine and trientine (used in Wilson disease) reduce copper. Proton pump inhibitors reduce zinc and potentially copper absorption. Patients on these medications have altered mineral baselines and need individualized guidance rather than a general supplement protocol.

Practical Co-Administration Summary

Take zinc and NMN/NR at any time of day. No evidence supports a mandatory separation window. Keep total daily zinc at or below 40 mg. Verify your multivitamin zinc content before adding standalone zinc. If you are supplementing zinc above 25 mg/day for more than 8 weeks, include 1-2 mg of copper daily (as copper glycinate or copper bisglycinate, which are well-tolerated forms) pubmed.ncbi.nlm.nih.gov/17016475 [7]. NMN doses between 250 mg and 1,200 mg/day and NR doses between 250 mg and 1,000 mg/day have the most human safety data [3] [4] [5].